Elevation Oncology Stock (NASDAQ: ELEV) stock price, news, charts, stock research, profile.
You can purchase shares of Elevation Oncology (NASDAQ:ELEV) through any online brokerage.
Other companies in Elevation Oncology’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), Intensity Therapeutics (NASDAQ:INTS) and CARISMA Therapeutics (NASDAQ:CARM).
Elevation Oncology has a consensus price target of $7.50.
The stock price for Elevation Oncology (NASDAQ: ELEV) is $0.5702 last updated October 31, 2024 at 4:06 PM EDT.
There are no upcoming dividends for Elevation Oncology.
Elevation Oncology’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Elevation Oncology.
Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.